Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mouse gut metagenome

ABSTRACT: Bazedoxifene and conjugated estrogen combination improves gut-liver axis health [microbiota]

PROVIDER: PRJNA360111 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR5144820_1.fastq.gz	Fastqsanger.gz
	SRR5144820_2.fastq.gz	Fastqsanger.gz
	SRR5144830_1.fastq.gz	Fastqsanger.gz
	SRR5144830_2.fastq.gz	Fastqsanger.gz
	SRR5144840_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 136

Similar Datasets

Bazedoxifene and conjugated estrogen combination improves gut-liver axis health

Project description:Bazedoxifene and conjugated estrogen combination improves gut-liver axis health

| PRJNA360113 | ENA

Mus musculus

Project description:Bazedoxifene and conjugated estrogen combination improves gut-liver axis health [mouse liver]

| PRJNA359187 | ENA

Bazedoxifene and conjugated estrogen combination improves gut-liver axis health [mouse liver]

Project description:Bazedoxifene and conjugated estrogens (CE+BZA) combination has been shown to prevent visceral adiposity and weight gain after menopause. However, its interaction with the microbiota has yet to be examined. In the present study, we use several –omics technologies to characterize the effects of various estrogens on the health of gut-liver axis. As reported in previous studies, CE+BZA combination is very effective at preventing ovariectomy-induced weight gain in mice fed a high-fat diet. Additionally, CE+BZA induces unique liver transcriptomic and blood metabolite profiles compared to estradiol, conjugated estrogens alone, and bazedoxifene alone. Several pathways and metabolites influenced are associated with lower rates of inflammation and overall benefits to gut and liver health. Finally, microbiome analysis shows that several bacterial species that potentially metabolize estrogens and affect their half-life in the body were significantly changed in CE+BZA treated mice. Our findings indicate a possible link between certain estrogens and gut microbiome and suggest a metabolic benefit of estrogens through manipulation of the gut-liver axis.

2018-02-13 | GSE92968 | GEO

Bazedoxifene and conjugated estrogen combination improves gut-liver axis health [microbiota]

2019-12-28 | GSE93096 | GEO

mouse gut metagenome

Project description:curdlan intakes improves gut microbial composition

| PRJDB11505 | ENA

Physiomimetic model of the human Gut-Liver axis for studies of inflammatory diseases

Project description:Association between the microbiome, IBD and liver diseases are known, yet cause and effect remain elusive. By connecting human microphysiological systems of the gut, liver and circulating Treg/Th17 cells, we modeled progression of ulcerative colitis (UC) ex vivo. We show that microbiome-derived short-chain fatty acids (SCFA) may either improve or worsen disease severity, depending on the activation state of CD4 T cells. Employing a multiomic approach, we found SCFA reduced innate activation of the UC gut and increased hepatic metabolism. However, during acute T cell-mediated inflammation, SCFA exacerbate CD4 T cell effector function leading to gut barrier disruption and liver damage. These paradoxical findings underscore the emerging utility of human physiomimetic technology in combination with systems immunology to study causality and temporal facets of gut-liver axis related diseases where animal models might leave ambiguity.

2021-06-03 | GSE135428 | GEO

Mouse Gut Microbiota

Project description:Dietary kale improves DSS induced gut dysbiosis

| PRJNA976322 | ENA

mouse gut metagenome

Project description:Quercetin improves gut dysbiosis in antibiotics-treated mice

| PRJNA607614 | ENA

pig gut metagenome

Project description:For weanling piglets, dietary micro-fibrillated cellulose improves gut health and performance

| PRJNA857838 | ENA

mouse gut metagenome

Project description:Dual benefit for the gut and liver: Bifidobacterium breve BBr60 improves gut microbiota balance and hepatic glucose metabolism in a high-fat diet-induced obese mouse model

| PRJNA1069785 | ENA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data